Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades […]
– Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer […]
TYSONS, Va., Jan. 06, 2025 (GLOBE NEWSWIRE) — TEGNA Inc. (NYSE: TGNA) today announced that Scott Dempsey has been named president and general manager […]